Fame and Mortality: Evidence from a Retrospective Analysis of Singers
November 26, 2025
Brand Name :
Zantac 360, Pepcid AC
Synonyms :
famotidine
Class :
Histamine H2 Antagonists
Dosage Forms & StrengthsÂ
Oral tabletÂ
10mgÂ
20mgÂ
40mgÂ
Chewable tabletÂ
10mgÂ
20mgÂ
SuspensionÂ
40mg/5mlÂ
Injectable solutionsÂ
0.4mg/mlÂ
10mg/mlÂ
20 mg orally/IV 2 times a day or 40 mg orally bedtime 8 weeks; may be increased up to 20 mg
40 mg orally at bedtime 8 weeks
Gastroesophageal Reflux Disease (GERD)Â
20 mg 2 times a day 6 weeks 
For Erosive diagnosed by endoscopy 20-40 mg orally 2 times a day 12 weeks 
Dosage Forms & StrengthsÂ
Oral tabletÂ
10mgÂ
20mgÂ
40mgÂ
Chewable tabletÂ
10mgÂ
20mgÂ
SuspensionÂ
40mg/5mlÂ
Injectable solutionsÂ
0.4mg/mlÂ
10mg/mlÂ
Age: 1-17 years 
0.25 mg/kg IV 2 times a day or 0.5 mg/kg PO at bedtime; may increase to 1 mg/kg once daily at bedtime or 0.5 mg/kg twice daily for up to 8 weeks;
Do not exceed 40 mg a day 
Refer to adult dosingÂ
may decrease the serum concentration and decrease in the efficacy
when ajmaline is used together with famotidine, the risk or seriousness of QTc prolongation is enhanced
When famotidine is used together with ouabain, this leads to reduction in famotidine excretion
caffeic acid when combined with famotidine results in more adverse effects
may have a decrease in excretion when combined with famotidine
When famotidine is aided by hesperetin, it reduces hesperetin’s metabolism
Actions and SpectrumÂ
The regulation of acid secretion has been affected in conditions like ulcers that are linked to acid hypersecretion. Famotidine inhibits the effects of histamine by acting on H2 receptors.Â
Spectrum:Â
Famotidine is used in treating a wide range of ulcers of the intestines and stomach. It also reduces symptoms like cough, heartburn, swallowing difficulties, and pain in the stomach.Â
Frequency DefinedÂ
1-10%Â
Constipation (1.2%)Â
Diarrhea (1.7%)Â
Headache (4.7%)Â
Dizziness (1.3%)Â
Frequency Not DefinedÂ
ArrhythmiaÂ
AV blockÂ
FeverÂ
FatigueÂ
Prolonged QT intervalÂ
AstheniaÂ
PalpitationÂ
Black Box WarningÂ
To be used in caution with patients suffering from kidney diseasesÂ
Contraindication/CautionÂ
Contraindication:Â
HypersensitivityÂ
Caution:Â
Kidney failureÂ
Gastric malignancyÂ
Pregnancy/LactationÂ
Pregnancy warnings:Â
US FDA pregnancy category: Not assignedÂ
Lactation:Â
Excreted into human milk is knownÂ
Pregnancy Categories:Â
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.Â
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant womenÂ
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant womenÂ
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this categoryÂ
PharmacologyÂ
It is a histamine H2 receptor antagonist. It leads to the reduction of acid generation thereby lowering the level of acid and pepsin which also decreases the quantity of gastric secretion. It has a suppressing effect in the basal and nocturnal gastric acid production.Â
Pharmacodynamics:Â
Famotidine acts by decreasing the acid secretion in the stomach which helps in relieving heartburn and indigestion that are mediated by acid. After oral administration of 5 to 40 mg it can achieve a dose-dependent mode of action resulting in suppression of both basal and stimulated gastric acid output. The 40-mg dosage reaches the maximum effect in 1 to 3 hours after taking the medication and remains active for 10 to 12 hours.Â
Pharmacokinetics:Â
AbsorptionÂ
Bioavailability is found to be 40 to 45% with a peak plasma time of 20 minutes when administered intravenously and 1h to 4h when administered orally.Â
DistributionÂ
15 to 20% of the drug is known to be protein-boundÂ
MetabolismÂ
It undergoes hepatic metabolism with famotidine S-oxide as the inactive metaboliteÂ
Elimination and excretionÂ
65-70% of the drug is eliminated through the renal route. 70% of it is eliminated in unchanged form through urine when administered intravenouslyÂ
Renal clearance- 250 to 450ml/minÂ
Half-life:Â
2 hours to 4 hoursÂ
AdministrationÂ
It is administered orally in the form of tablets before mealsÂ
Patient Information LeafletÂ
Generic Name: famotidineÂ
Why do we use famotidine?Â
Famotidine belongs to the class of histamine-2 receptor antagonists which is utilized for various medical purposes:Â
Gastric Acid Reduction: It reduces the gastric acid production and effectively treats peptic ulcer. It is used for the purpose of controlling conditions like acid reflux and ulcers because reducing the acidity levels in the stomach helps to calm the same down.Â
Peptic Ulcer Treatment: It is one of the effective medicines to treat duodenal ulcer and gastric stases by decreasing the digestive acidic secretion and it protects from the injury as well as the relapse of peptic ulcer.Â
Gastroesophageal Reflux Disease (GERD): It is used to treat GERD which is the condition of stomach acid regurgitation into the esophagus causing heartburn and regurgitation.Â
Prevention of Stress Ulcers: Famotidine is typically used in the hospitalized patients as well as during procedures that can cause stress ulcers.Â